According to Sarkar and his team, insulin vials/syringes use in American patients with T2DM has reduced from 63.9% in 2016 to 41.1% in 2020, while insulin pens have increased from 36.1% to 58.7% between 2016 and 2020 [33]. This evidence concerns the gene INS and type 2 diabetes mellitus.